A Comprehensive Review of Ulcer Pathogenesis, Treatment Modalities, and Impact on Patient Well-being

Abstract

Ulcers, characterized by disruptions in tissue integrity, pose a significant global health challenge, affecting millions and impacting their quality of life. While often associated with diabetes, the etiology of ulcers is multifactorial, encompassing vascular insufficiency, pressure, infection, and inflammatory processes. This review provides a comprehensive overview of ulcer pathogenesis, encompassing a broad spectrum of ulcer types beyond diabetic foot ulcers (DFUs), including venous leg ulcers (VLUs), pressure ulcers (PUs), and arterial ulcers. We delve into the complex interplay of risk factors, clinical presentation, diagnostic approaches, and prognostic indicators for each ulcer type. Furthermore, we critically examine both conventional and advanced treatment modalities, with a particular focus on regenerative medicine strategies, such as fish-skin grafts, and their potential to revolutionize ulcer management. Finally, we address the profound impact of ulcers on patient well-being, highlighting the physical, psychological, and socioeconomic burdens associated with these chronic wounds. This review aims to provide experts in the field with a comprehensive understanding of ulcer biology, facilitating the development of more effective and patient-centered treatment strategies.

Many thanks to our sponsor Esdebe who helped us prepare this research report.

1. Introduction

Ulcers represent a significant clinical burden worldwide, impacting millions of individuals and imposing substantial economic costs on healthcare systems. Defined as a discontinuity of tissue integrity involving epithelial and often sub-epithelial layers, ulcers can arise from diverse underlying pathologies, ranging from chronic venous insufficiency to pressure-induced ischemia and metabolic disorders like diabetes mellitus. Understanding the diverse etiological factors, coupled with advances in diagnostic and therapeutic strategies, is crucial for optimizing patient outcomes and mitigating the detrimental impact of ulcers on quality of life. While the use of fish-skin grafts for treating diabetic foot ulcers has gained considerable attention, it’s imperative to recognize that ulcers represent a heterogeneous group of conditions, each with unique underlying mechanisms and treatment requirements. Therefore, a comprehensive review of ulcer pathogenesis, diagnostic approaches, and therapeutic interventions is warranted to provide a holistic understanding of this complex clinical problem.

Many thanks to our sponsor Esdebe who helped us prepare this research report.

2. Classification and Pathogenesis of Ulcers

Ulcers are broadly classified based on their underlying etiology, with the most prevalent types including venous leg ulcers (VLUs), arterial ulcers, pressure ulcers (PUs), and diabetic foot ulcers (DFUs). Each ulcer type exhibits distinct pathophysiological mechanisms.

2.1. Venous Leg Ulcers (VLUs): VLUs are the most common type of leg ulcer, accounting for approximately 70% of all cases. Their pathogenesis revolves around chronic venous insufficiency (CVI), a condition characterized by impaired venous return from the lower extremities. Prolonged venous hypertension damages the microvasculature, leading to capillary leakage, fibrin cuff formation around capillaries, and impaired oxygen diffusion to surrounding tissues. Leukocyte trapping and activation further contribute to tissue damage through the release of inflammatory mediators and reactive oxygen species. Risk factors for VLUs include advanced age, obesity, deep vein thrombosis (DVT), and a history of leg trauma. Clinically, VLUs typically present as shallow, irregular ulcers located around the medial malleolus (inner ankle), often accompanied by edema, hyperpigmentation, and lipodermatosclerosis (thickening and hardening of the skin).

2.2. Arterial Ulcers: Arterial ulcers, also known as ischemic ulcers, arise from inadequate arterial blood flow to the lower extremities. Peripheral artery disease (PAD), commonly caused by atherosclerosis, is the primary underlying factor. Reduced blood supply leads to chronic tissue ischemia, rendering the tissues vulnerable to breakdown. Even minor trauma or pressure can trigger ulcer formation in the presence of compromised arterial perfusion. Risk factors for arterial ulcers include smoking, diabetes, hypertension, hyperlipidemia, and a family history of PAD. Arterial ulcers typically present as deep, painful lesions with well-defined borders, often located on the toes, feet, or lower legs. The surrounding skin is typically cool, pale, and hairless, with diminished or absent pedal pulses.

2.3. Pressure Ulcers (PUs): PUs, also known as bedsores or decubitus ulcers, develop as a result of prolonged pressure on bony prominences, leading to tissue ischemia and necrosis. The duration and intensity of pressure are key determinants of PU formation. Shearing forces, friction, and moisture further exacerbate the risk. Immobility, malnutrition, incontinence, and impaired sensation are major risk factors for PUs. PUs are classified into stages based on the depth of tissue involvement, ranging from Stage I (non-blanchable erythema) to Stage IV (full-thickness tissue loss with exposed bone, tendon, or muscle). The sacrum, coccyx, heels, and hips are common sites for PU development.

2.4. Diabetic Foot Ulcers (DFUs): DFUs are a major complication of diabetes mellitus, affecting approximately 15% of individuals with diabetes during their lifetime. The pathogenesis of DFUs is multifactorial, involving peripheral neuropathy, peripheral artery disease (PAD), and impaired immune function. Diabetic neuropathy leads to loss of sensation in the feet, predisposing individuals to unnoticed trauma and repetitive stress. PAD further compromises blood supply to the lower extremities, impairing wound healing. Impaired immune function increases susceptibility to infection, which can significantly delay wound closure. Hyperglycemia also contributes to impaired wound healing by inhibiting fibroblast function and collagen synthesis. DFUs typically occur on the plantar surface of the foot, often at sites of repetitive pressure or minor trauma. They can range in severity from superficial lesions to deep, infected ulcers that penetrate bone.

Many thanks to our sponsor Esdebe who helped us prepare this research report.

3. Risk Factors and Predisposing Conditions

Identifying and addressing risk factors is crucial for ulcer prevention and management. Several factors contribute to the development of ulcers across different etiologies:

• Vascular Insufficiency: Both venous and arterial insufficiency are major risk factors for leg ulcers. Venous hypertension in CVI and reduced arterial perfusion in PAD compromise tissue oxygenation and nutrient delivery, making tissues vulnerable to ulceration.
• Diabetes Mellitus: Diabetes significantly increases the risk of DFUs and can also impair wound healing in other types of ulcers. Hyperglycemia, neuropathy, PAD, and impaired immune function contribute to the pathogenesis of DFUs.
• Immobility: Prolonged immobility increases the risk of PUs by concentrating pressure on bony prominences. Conditions that limit mobility, such as paralysis, stroke, and prolonged hospitalization, are major risk factors.
• Age: Advanced age is a risk factor for all types of ulcers. Age-related changes in skin structure, vascular function, and immune response increase susceptibility to ulceration.
• Obesity: Obesity increases the risk of VLUs and DFUs by contributing to venous hypertension, impaired lymphatic drainage, and insulin resistance.
• Smoking: Smoking impairs wound healing and increases the risk of arterial ulcers by damaging blood vessels and reducing tissue oxygenation.
• Malnutrition: Malnutrition impairs wound healing by limiting the availability of essential nutrients, such as protein, vitamins, and minerals. Adequate nutritional support is crucial for ulcer management.
• Immunosuppression: Immunosuppression, whether due to medications (e.g., corticosteroids, immunosuppressants) or underlying conditions (e.g., HIV/AIDS), increases the risk of infection and impairs wound healing.
• Incontinence: Urinary and fecal incontinence increase the risk of PUs by causing skin maceration and increasing the risk of infection.
• Previous Ulcer History: Individuals with a history of ulcers are at increased risk of recurrence.

Many thanks to our sponsor Esdebe who helped us prepare this research report.

4. Clinical Presentation, Signs, and Symptoms

The clinical presentation of ulcers varies depending on the underlying etiology, location, and severity. Recognizing the distinct clinical features of each ulcer type is essential for accurate diagnosis and appropriate management.

4.1. Venous Leg Ulcers (VLUs):

• Location: Typically located around the medial malleolus (inner ankle).
• Appearance: Shallow, irregular ulcers with a granulating base.
• Exudate: Moderate to heavy exudate.
• Pain: Mild to moderate pain, often described as aching or throbbing.
• Associated Signs: Edema, hyperpigmentation, lipodermatosclerosis, varicose veins.

4.2. Arterial Ulcers:

• Location: Commonly located on the toes, feet, or lower legs.
• Appearance: Deep, painful lesions with well-defined borders; often have a “punched-out” appearance.
• Exudate: Minimal exudate.
• Pain: Severe pain, especially at night, often relieved by dependency (hanging the leg down).
• Associated Signs: Cool, pale skin; hair loss on the affected limb; diminished or absent pedal pulses; claudication (pain with walking).

4.3. Pressure Ulcers (PUs):

• Location: Over bony prominences, such as the sacrum, coccyx, heels, and hips.
• Appearance: Variable, depending on the stage of the ulcer. Stage I ulcers present as non-blanchable erythema; Stage II ulcers involve partial-thickness skin loss; Stage III ulcers involve full-thickness skin loss with subcutaneous tissue involvement; Stage IV ulcers involve full-thickness tissue loss with exposed bone, tendon, or muscle.
• Exudate: Variable, depending on the stage and presence of infection.
• Pain: Variable, depending on the stage and nerve involvement.
• Associated Signs: Surrounding skin may be red, inflamed, or macerated.

4.4. Diabetic Foot Ulcers (DFUs):

• Location: Typically located on the plantar surface of the foot, often at sites of repetitive pressure or minor trauma.
• Appearance: Variable, ranging from superficial lesions to deep, infected ulcers.
• Exudate: Variable, depending on the presence of infection.
• Pain: May be absent or reduced due to peripheral neuropathy.
• Associated Signs: Peripheral neuropathy (loss of sensation), peripheral artery disease (diminished pulses), foot deformities (e.g., Charcot foot).

Many thanks to our sponsor Esdebe who helped us prepare this research report.

5. Diagnostic Approaches

A thorough diagnostic evaluation is essential for determining the underlying cause of an ulcer and guiding appropriate management. Diagnostic approaches include:

• History and Physical Examination: A detailed history, including medical history, medications, and risk factors, is crucial. A comprehensive physical examination should assess the ulcer’s location, size, depth, appearance, and surrounding skin. Vascular assessment, including palpation of pulses and ankle-brachial index (ABI) measurement, is essential for evaluating arterial perfusion. Neurological examination should assess sensation and reflexes in the lower extremities, particularly in individuals with diabetes.
• Wound Cultures: Wound cultures are indicated for ulcers that exhibit signs of infection, such as purulent drainage, erythema, warmth, or pain. Cultures should be obtained after wound debridement to ensure accurate identification of causative organisms. Both aerobic and anaerobic cultures should be performed.
• Vascular Studies: Non-invasive vascular studies, such as ABI, pulse volume recordings (PVRs), and duplex ultrasound, are used to assess arterial perfusion and identify areas of stenosis or occlusion. Angiography may be necessary in selected cases to further evaluate arterial anatomy and plan for revascularization procedures.
• Biopsy: Ulcer biopsy may be indicated to rule out other underlying conditions, such as malignancy, vasculitis, or pyoderma gangrenosum. Biopsy specimens should be obtained from the edge of the ulcer.
• Imaging Studies: Imaging studies, such as X-rays, CT scans, or MRI, may be used to evaluate for osteomyelitis (bone infection) or deep tissue abscesses, particularly in DFUs.

Many thanks to our sponsor Esdebe who helped us prepare this research report.

6. Treatment Modalities

The treatment of ulcers is multifaceted and should be tailored to the specific ulcer type, underlying etiology, and patient characteristics. Treatment modalities include:

6.1. Wound Bed Preparation:

• Debridement: Debridement, the removal of necrotic tissue and debris from the wound bed, is a cornerstone of ulcer management. Debridement promotes wound healing by removing barriers to cell migration and proliferation. Several debridement methods are available, including sharp debridement (using a scalpel or scissors), enzymatic debridement (using topical enzymes), autolytic debridement (using the body’s own enzymes), and mechanical debridement (using wet-to-dry dressings or pulsed lavage).
• Wound Cleansing: Regular wound cleansing is essential for removing debris and preventing infection. Normal saline is the preferred cleansing solution.
• Moisture Balance: Maintaining appropriate moisture balance in the wound bed is crucial for optimal wound healing. Both excessive dryness and excessive moisture can impair healing. Various wound dressings are available to regulate moisture levels.

6.2. Wound Dressings:

A wide variety of wound dressings are available, each with specific properties and indications. Common types of wound dressings include:

• Gauze Dressings: Gauze dressings are inexpensive and readily available but have limited moisture-retentive properties. They are often used for packing deep wounds or for mechanical debridement.
• Foam Dressings: Foam dressings are highly absorbent and provide cushioning and protection. They are suitable for wounds with moderate to heavy exudate.
• Alginate Dressings: Alginate dressings are derived from seaweed and are highly absorbent. They are suitable for heavily exuding wounds and can promote hemostasis.
• Hydrocolloid Dressings: Hydrocolloid dressings are occlusive or semi-occlusive dressings that promote a moist wound environment. They are suitable for wounds with light to moderate exudate.
• Hydrogel Dressings: Hydrogel dressings are highly hydrating and provide a moist wound environment. They are suitable for dry wounds and can promote autolytic debridement.
• Film Dressings: Film dressings are transparent, adhesive dressings that provide a barrier against bacteria and moisture. They are suitable for superficial wounds and for protecting intact skin.

6.3. Compression Therapy:

Compression therapy is the cornerstone of VLU management. Compression reduces venous hypertension, improves venous return, and promotes wound healing. Various compression modalities are available, including compression bandages, compression stockings, and pneumatic compression devices.

6.4. Revascularization:

Revascularization procedures, such as angioplasty or bypass surgery, are indicated for arterial ulcers with significant arterial insufficiency. Revascularization improves blood flow to the affected limb and promotes wound healing.

6.5. Offloading:

Offloading, the reduction of pressure on the ulcerated area, is crucial for DFU management. Offloading can be achieved with various devices, such as total contact casts, removable cast walkers, and therapeutic footwear.

6.6. Infection Control:

Infection is a major barrier to wound healing. Systemic antibiotics are indicated for ulcers with signs of systemic infection, such as fever, chills, or leukocytosis. Topical antimicrobials may be used for localized infections.

6.7. Advanced Therapies:

Advanced wound care therapies are used to promote wound healing in chronic, non-healing ulcers. These therapies include:

• Negative Pressure Wound Therapy (NPWT): NPWT applies controlled negative pressure to the wound bed, promoting granulation tissue formation, reducing edema, and improving blood flow.
• Hyperbaric Oxygen Therapy (HBOT): HBOT increases the partial pressure of oxygen in the blood, promoting wound healing and reducing infection.
• Growth Factors: Topical growth factors, such as platelet-derived growth factor (PDGF), can stimulate cell proliferation and collagen synthesis.
• Skin Substitutes: Skin substitutes, also known as bioengineered skin, provide a scaffold for cell migration and tissue regeneration. Examples include acellular dermal matrices, cellular skin substitutes, and synthetic skin substitutes.
• Fish-Skin Grafts: Fish skin grafts, derived from Omega-3 rich fish skin (typically cod), are showing promising results in DFU treatment. These grafts are rich in collagen and growth factors which promote angiogenesis and wound closure. Fish skin grafts offers a less invasive and costly option than traditional skin grafts.

6.8. Regenerative Medicine:

Regenerative medicine approaches hold great promise for promoting wound healing in chronic ulcers. These approaches aim to stimulate tissue regeneration and restore tissue function. Regenerative medicine strategies include:

• Cell Therapy: Cell therapy involves the transplantation of cells, such as fibroblasts, keratinocytes, or stem cells, into the wound bed to promote tissue regeneration.
• Gene Therapy: Gene therapy involves the delivery of genes that encode for growth factors or other wound-healing molecules into the wound bed.
• Extracellular Matrix (ECM) Scaffolds: ECM scaffolds provide a three-dimensional matrix that supports cell adhesion, migration, and differentiation. ECM scaffolds can be derived from various sources, including animal tissues and synthetic materials.

Many thanks to our sponsor Esdebe who helped us prepare this research report.

7. Prognosis

The prognosis for ulcer healing varies depending on the ulcer type, underlying etiology, patient characteristics, and adherence to treatment. Factors associated with poor prognosis include:

• Large ulcer size: Larger ulcers are more difficult to heal.
• Deep ulcers: Deeper ulcers require more extensive tissue regeneration.
• Presence of infection: Infection significantly impairs wound healing.
• Underlying medical conditions: Conditions such as diabetes, PAD, and venous insufficiency can impair wound healing.
• Non-adherence to treatment: Poor adherence to treatment, such as compression therapy or offloading, can delay wound healing.
• Malnutrition: Malnutrition impairs wound healing.
• Smoking: Smoking impairs wound healing.

Many thanks to our sponsor Esdebe who helped us prepare this research report.

8. Impact on Patient Quality of Life

Ulcers can have a profound impact on patient quality of life, affecting physical, psychological, and socioeconomic well-being. The physical burden of ulcers includes pain, limited mobility, sleep disturbances, and increased risk of infection and amputation. The psychological burden includes anxiety, depression, social isolation, and body image concerns. The socioeconomic burden includes lost productivity, increased healthcare costs, and financial strain.

• Physical Impact: Chronic pain is a common symptom of ulcers, particularly arterial ulcers. Pain can interfere with daily activities, sleep, and overall quality of life. Limited mobility due to ulcers can lead to muscle atrophy, joint stiffness, and increased risk of falls. Ulcers can also increase the risk of infection, which can lead to sepsis and amputation.
• Psychological Impact: Ulcers can lead to anxiety, depression, and social isolation. Patients may feel embarrassed or ashamed of their ulcers and may avoid social activities. Chronic pain and limited mobility can also contribute to psychological distress.
• Socioeconomic Impact: Ulcers can lead to lost productivity, increased healthcare costs, and financial strain. Patients may be unable to work due to their ulcers, leading to loss of income. The cost of ulcer treatment, including wound dressings, medications, and hospitalizations, can be substantial.

Many thanks to our sponsor Esdebe who helped us prepare this research report.

9. Prevention Strategies

Preventing ulcers is crucial for reducing the burden of these chronic wounds. Prevention strategies include:

• Risk Factor Modification: Addressing modifiable risk factors, such as smoking, obesity, and hypertension, can reduce the risk of ulcers.
• Skin Care: Maintaining good skin hygiene and moisturizing dry skin can prevent skin breakdown.
• Pressure Relief: Frequent repositioning and the use of pressure-reducing devices can prevent PUs.
• Foot Care: Regular foot examinations, proper footwear, and prompt treatment of foot lesions can prevent DFUs.
• Compression Therapy: Compression therapy can prevent VLUs in individuals with CVI.
• Patient Education: Educating patients about ulcer risk factors, prevention strategies, and proper wound care is essential for promoting self-management and reducing the risk of recurrence.

Many thanks to our sponsor Esdebe who helped us prepare this research report.

10. Future Directions

Future research should focus on developing more effective and patient-centered ulcer treatment strategies. Areas of promising research include:

• Novel Wound Dressings: Development of wound dressings that promote angiogenesis, reduce inflammation, and enhance tissue regeneration.
• Targeted Therapies: Development of targeted therapies that address the specific underlying causes of ulcers.
• Regenerative Medicine: Further investigation of regenerative medicine approaches, such as cell therapy and gene therapy, for promoting wound healing.
• Biomarkers: Identification of biomarkers that can predict ulcer risk and prognosis.
• Personalized Medicine: Tailoring ulcer treatment to individual patient characteristics and needs.

Many thanks to our sponsor Esdebe who helped us prepare this research report.

11. Conclusion

Ulcers represent a significant clinical challenge, impacting millions of individuals and imposing substantial economic costs on healthcare systems. The etiology of ulcers is multifactorial, encompassing vascular insufficiency, pressure, infection, and inflammatory processes. Effective ulcer management requires a comprehensive approach that addresses the underlying cause, promotes wound healing, and alleviates pain and suffering. Advanced therapies, including regenerative medicine strategies like fish-skin grafts, hold promise for improving outcomes in chronic, non-healing ulcers. Further research is needed to develop more effective and patient-centered treatment strategies and to prevent the development of ulcers in high-risk individuals. A greater emphasis on preventative strategies is essential.

Many thanks to our sponsor Esdebe who helped us prepare this research report.

References

• Guest, J. F., Ayoub, N., McIlwraith, T., Uchegbu, I., Murray, A., & Underwood, J. (2017). Health economic burden that wounds impose on the National Health Service in the UK. BMJ open, 7(12), e013863.
• Harding, K. G., Moore, P., & Doherty, D. (2002). Consensus recommendations for wound bed preparation: an update. WOUNDS UK, 6(Suppl 1), 1-20.
• Lazarus, G. S., Cooper, D. M., Knighton, D. R., Margolis, D. J., Pecoraro, R. E., Rodeheaver, G., & Yager, D. R. (1994). Definitions and guidelines for assessment of wounds and evaluation of healing. Archives of dermatology, 130(4), 489-493.
• Frykberg, R. G., Banks, J. (2015). Challenges in the Treatment of Chronic Wounds. Advances in Wound Care, 4(9), 560-582.
• Sen, C. K. (2019). Human Wound and Its Repair: An Updated Overview. Advances in Wound Care, 8(2), 39-61.
• Armstrong DG, Boulton AJM, Bus SA. Diabetic foot ulcers and their recurrence. N Engl J Med. 2017;376(24):2367-2375.
• Olsson M, Järbrink K, Divakar U, Bajpai R, Upton Z, Schmidtchen A, Car J. The humanistic and economic burden of chronic wounds: A systematic review. Wound Repair Regen. 2019 Mar;27(2):114-125.
• Than, M. C., Bejder, J., Carville, K., Bjarnsholt, T., & Serena, T. E. (2023). Fish skin: a novel approach to wound healing and tissue regeneration. International Wound Journal, 20(1), 24–37. https://doi.org/10.1111/iwj.13836
• Snyder, R. J., Bryant, R., & Giurini, J. M. (2016). Wound Bed Preparation. Clinics in Podiatric Medicine and Surgery, 33(4), 465–478. https://doi.org/10.1016/j.cpm.2016.06.002